174 related articles for article (PubMed ID: 16039870)
21. Oncogene-induced senescence as an initial barrier in lymphoma development.
Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA
Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837
[TBL] [Abstract][Full Text] [Related]
22. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.
Martínez-Cruz AB; Santos M; Lara MF; Segrelles C; Ruiz S; Moral M; Lorz C; García-Escudero R; Paramio JM
Cancer Res; 2008 Feb; 68(3):683-92. PubMed ID: 18245467
[TBL] [Abstract][Full Text] [Related]
24. On the karyotypic origin and evolution of cancer cells.
Nicholson JM; Duesberg P
Cancer Genet Cytogenet; 2009 Oct; 194(2):96-110. PubMed ID: 19781442
[TBL] [Abstract][Full Text] [Related]
25. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC
Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694
[TBL] [Abstract][Full Text] [Related]
26. Tumor suppressor genetics.
Payne SR; Kemp CJ
Carcinogenesis; 2005 Dec; 26(12):2031-45. PubMed ID: 16150895
[TBL] [Abstract][Full Text] [Related]
27. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
28. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
[TBL] [Abstract][Full Text] [Related]
29. Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling.
Li L; Abdel Fattah E; Cao G; Ren C; Yang G; Goltsov AA; Chinault AC; Cai WW; Timme TL; Thompson TC
Cancer Res; 2008 Jan; 68(2):434-43. PubMed ID: 18199537
[TBL] [Abstract][Full Text] [Related]
30. Mutant p53 gain of oncogenic function: in vivo evidence, mechanism of action and its clinical implications.
Adhikari AS; Iwakuma T
Fukuoka Igaku Zasshi; 2009 Jun; 100(6):217-28. PubMed ID: 19670804
[TBL] [Abstract][Full Text] [Related]
31. P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells.
Ridgeway AG; McMenamin J; Leder P
Oncogene; 2006 Jun; 25(25):3518-27. PubMed ID: 16434961
[TBL] [Abstract][Full Text] [Related]
32. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
[TBL] [Abstract][Full Text] [Related]
33. Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras.
Kalas W; Yu JL; Milsom C; Rosenfeld J; Benezra R; Bornstein P; Rak J
Cancer Res; 2005 Oct; 65(19):8878-86. PubMed ID: 16204059
[TBL] [Abstract][Full Text] [Related]
34. Differential oncogenic potential of activated RAS isoforms in melanocytes.
Whitwam T; Vanbrocklin MW; Russo ME; Haak PT; Bilgili D; Resau JH; Koo HM; Holmen SL
Oncogene; 2007 Jul; 26(31):4563-70. PubMed ID: 17297468
[TBL] [Abstract][Full Text] [Related]
35. Zebrafish as a cancer model.
Feitsma H; Cuppen E
Mol Cancer Res; 2008 May; 6(5):685-94. PubMed ID: 18505914
[TBL] [Abstract][Full Text] [Related]
36. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
37. An in vitro multistep carcinogenesis model for human cervical cancer.
Narisawa-Saito M; Yoshimatsu Y; Ohno S; Yugawa T; Egawa N; Fujita M; Hirohashi S; Kiyono T
Cancer Res; 2008 Jul; 68(14):5699-705. PubMed ID: 18632622
[TBL] [Abstract][Full Text] [Related]
38. Clonal selection versus genetic instability as the driving force in neoplastic transformation.
Chow M; Rubin H
Cancer Res; 2000 Nov; 60(22):6510-8. PubMed ID: 11103821
[TBL] [Abstract][Full Text] [Related]
39. A mathematical model of breast cancer development, local treatment and recurrence.
Enderling H; Chaplain MA; Anderson AR; Vaidya JS
J Theor Biol; 2007 May; 246(2):245-59. PubMed ID: 17289081
[TBL] [Abstract][Full Text] [Related]
40. The evolutionary origin of genetic instability in cancer development.
Breivik J
Semin Cancer Biol; 2005 Feb; 15(1):51-60. PubMed ID: 15613288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]